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 RNA-Seq is a recently developed technology that can reveal RNA expression 
profile by taking advantage of deep sequencing. This new technology has many 
advantages over microarray technologies. Although RNA-Seq is expected to overtake 
microarray experiments due to their massive amounts of data produced, it presents many 
challenges to bioinformatics research regarding efficient data processing and storage, and 
accuracy in data interpretation. One of the challenges and also an important aspect of 
expression profiling is to detect differentially expressed genes between different 
experimental conditions. Several statistical methods have been developed over the past 
few years. In this study, we chose two representative methods: one parametric method, 
DESeq, and one nonparametric method, NOISeq. We compared the performance of these 
two methods using simulated and real datasets. We showed that both DESeq and NOISeq 
identified over-expressed genes more correctly than under-expressed ones. While DESeq 
was more likely to call longer genes as differentially expressed, NOISeq did not show 
such bias. When the underlying variation increased, both methods showed higher false-
positive rates at the same threshold. When replicates were not available, both methods 
  
 
 
showed lower true-positive and higher false-positive rates. Finally, we explored a 
strategy to combine the results from DESeq and NOISeq when replicates are available. 
We showed that it is possible to improve differential gene-calling results by combining 
the results obtained from the two methods. NOISeq is recommended when no replicate is 
available. 
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1 Introduction 
 
1.1 Gene Expression Analysis 
 
Gene expression analysis has long been of interest to molecular biologists. It is 
done, for example, to identify genes differentially expressed among tissues or among 
different experimental conditions, to discriminate heterogeneous diseases such as cancer, 
or to elucidate the relationship between gene expression and covariates such as survival 
or tumor grade (Barry, et al., 2005). The transcriptome is the complete set of transcripts 
in a cell and a summary of all gene expressions. It is essential to construct and understand 
the transcriptome accurately in order to interpret the functional elements of the genome, 
molecular constituents of cells, development of organisms, and mechanism of diseases 
(Wang, et al., 2009).  
Various technologies have been developed to quantify and analyze transcriptomes 
over the years. Early technologies such as labor-intensive and expensive cDNA cloning 
and expressed sequence tag (EST) provided only a limited insight to the complexity and 
intricacy of transcriptomes (Garber, et al., 2011). Microarray technology was then 
developed to overcome such limitations for its high throughput and relatively low cost. It 
is a hybridization-based approach that incubates fluorescently labeled cDNA with either 
custom-made microarrays or commercial oligo-based microarrays. Microarray provided 
more comprehension to the transcriptome analysis since it can generate the expression 
data for thousands of genes simultaneously. Limitations, however, exist also in 
microarray, e.g., requiring prior knowledge about the genome sequence, high background 
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noise due to cross-hybridization, and a limited dynamic range of detection owing to 
background noise and saturation of signals (Wang, et al., 2009). 
 
1.2 Next-Generation Sequencing and RNA-Seq 
 
Next-generation sequencing technologies have been developed in recent years. It 
is significantly different from the traditional Sanger sequencing technology. First of all, 
next-generation sequencing is ultra high-throughput, which processes millions of 
sequence reads in a parallel fashion instead of sequentially. Secondly, the workflow to 
produce next-generation sequencing libraries is different. Instead of using vector-based 
cloning and Escherichia coli based amplification, next-generation sequencing workflow 
is to ligate specific adaptor oligos to both ends of each DNA fragment and then sequence 
these DNA fragments. Moreover, next-generation sequencers produce shorter reads in 
length compared to Sanger sequencing. Depending on different technologies or platforms 
(e.g., Illumina1, SOLiD2, Roche 4543, Ion Torrent4, and PacBio5), reads can vary in 
length between around 30bp and 400bp (or ~1,000bp for PacBio), which can be ~20 
times shorter than those from Sanger sequencing.  
With the massive amount of short reads produced by next-generation sequencers, 
traditional alignment programs, e.g., BLAST (Altschul, et al., 1990), are too slow and not 
suitable for mapping all short reads to reference genomes. Various programs have been 
                                                        
1http://www.illumina.com/ 
2http://www.appliedbiosystems.com/absite/us/en/home.html 
3http://www.my454.com/ 
4http://www.iontorrent.com/ 
5http://www.pacificbiosciences.com/ 
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developed to resolve the issue. Some examples include Bowtie (Langmead, et al., 2009), 
TopHat (Trapnell, et al., 2009), BWA (Li and Durbin, 2009), and SOAP2 (Li, et al., 
2009). Unlike regular pairwise-alignment methods based on dynamic programming such 
as the Smith-Waterman algorithm (Smith and Waterman, 1981) or a heuristic algorithm 
as BLAST, these short-read aligners use algorithms based on hash tables or Burrows-
Wheeler transform (Burrows and Wheeler, 1994). Ruffalo et al. (2011) compared seven 
popular short-read alignment programs: Bowtie, BWA, SOAP2, mrFAST (Alkan, et al., 
2009), mrsFAST (Hach, et al., 2010), Novoalign6, and SHRiMP (Rumble, et al., 2009). 
They reported that among these programs, SOAP2 performed quite well and had a 
consistently high accuracy (above 90%) even when the short-read error rates were as high 
as 10%. 
With these newly developed tools, next-generation sequencing are now used in 
many aspects of biological research, e.g., mutation discovery, sequencing clinical isolates 
in strain-to-reference comparisons, enabling metagenomics, defining DNA-protein 
interactions, discovering noncoding RNAs, and even de-novo assembly of transcriptomic 
and genomic sequences (Mardis, 2008). One particular use of next-generation sequencing 
technology this thesis focuses on is for quantifying gene expression, which is called 
RNA-Seq. 
RNA-Seq is a recently developed technology based on next-generation 
sequencing. It is used, for example, to obtain gene-expression profiles, transcriptional 
structure of genes, and post-transcriptional modifications. RNA-Seq measures the levels 
of transcripts and their isoforms (alternatively spliced transcripts from the same gene) 
                                                        
6http://www.novocraft.com/main/index.php 
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much more precisely than many other methods. RNA-Seq data are typically generated 
from a library of cDNA fragments made from a population of RNAs. The cDNA 
fragments are attached with adaptors on one or both ends (single or paired-end 
sequencing). Then each molecule is sequenced in a high-throughput fashion with or 
without amplification. The short reads obtained are aligned to a reference genome or 
transcriptome. They can be assembled de novo if the reference is not available. The 
number of short reads that are mapped to each reference gene region or transcript can be 
interpreted as the expression level of the gene or transcript. Illumina and SOLiD 
platforms are usually used for RNA-Seq experiments. Many different types of analyses, 
e.g., single nucleotide polymorphism discovery, alternative transcript identification, and 
gene expression profiling, can be applied on the result of short-read alignment. Compared 
with aforementioned microarray technology, RNA-Seq has many advantages, e.g., high 
resolution, low background noise, no prior knowledge of reference sequence required, 
and being able to distinguish isoforms and allelic expression (Wang, et al., 2009).  
 
1.3 RNA-Seq Data Processing and Analysis 
 
It is expected that digital gene expression (DGE) technologies (e.g., RNA-Seq) 
will overtake microarray technologies in the near future for many functional genomics 
applications (Robinson, et al., 2010). It necessitates, however, development of accurate 
and efficient methods and software to analyze DGE data. The number of short reads 
mapped onto one gene is the count that can be viewed as the expression level of the gene. 
These count data are different from those obtained from bead and array technologies. 
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DGE data are fundamentally discrete, rather than continuous as microarray data are, in 
nature (Hardcastle and Kelly, 2010). Therefore, the techniques developed for analyzing 
microarray data may not be directly applicable on these DGE data. 
Two types of variations exist in microarray as well as in RNA-Seq experiments: 
biological variation and technical variation. Biological variation is the normal stochastic 
variation in gene expression between biological samples. Technical variation is the 
inherent variation of the experimental process. For example, in microarray experiments, 
technical variation is produced as different signals in different runs of microarray for a 
same biological sample. In RNA-Seq experiments, different numbers of short reads are 
produced in different runs of sequencing for a same biological sample. For continuous 
data obtained by microarray, a normal distribution is usually used to model biological and 
technical variations after log transformation (Smyth, et al., 2005). However, as mentioned 
previously, since RNA-Seq count data are not continuous but discrete, the techniques 
developed for analyzing microarray data are not applicable on RNA-Seq data. Since 
Poisson distribution cannot model the over-dispersion observed in RNA-Seq data, both 
technical and biological variations have been modeled using negative binomial (over-
dispersed Poisson) distributions (Robinson, et al., 2010). 
Since the number of reads generated from each transcript depends on the length of 
the transcript and the depth of the sequencing, Mortazavi et al. (2008) introduced RPKM 
(Reads Per Kilobase of exon model per Million mapped reads) to normalize the estimated 
expression level of each transcript based on the length. RPKM, however, has several 
drawbacks. The fact that a small number of highly expressed genes can generate a big 
portion of the total reads (Bullard, et al., 2010) complicates normalization. It also has 
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been reported that even after normalization based on length (e.g., RPKM), longer 
transcripts or genes are still more prone to be called as differentially expressed than 
shorter ones using t-test (Oshlack and Wakefield, 2009). Moreover, expression levels of 
genes or transcripts cause bias in detecting differential expression; highly expressed 
genes or transcripts are more likely to be called as differentially expressed (Wu, et al., 
2010). Non-uniform read coverage as results of experimental protocols and local 
sequence context also exists and some correction methods have been developed 
(Benjamini and Speed, 2012; Hansen, et al., 2010; Li, et al., 2010). 
 
1.4 Methods Used to Analyze RNA-Seq Differential Gene Expression 
 
Despite all the challenges, several methods have been developed to analyze DGE 
data over the last few years. They include DESeq (Anders and Huber, 2010), edgeR 
(Robinson, et al., 2010), Cuffdiff (Trapnell, et al., 2010), baySeq (Hardcastle and Kelly, 
2010), TSPM (Auer and Doerge, 2011), BitSeq (Glaus, et al., 2012), and NOISeq 
(Tarazona, et al., 2011). Each of these methods is described next. 
 
1.4.1 DESeq 
 
DESeq (Anders and Huber, 2010) is a parametric statistics method based on a 
negative binomial model (an over-dispersed Poisson model; NB). It takes raw read counts 
as input. It assumes that the counts follow: 
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,        (1) 
where Kij is the number of read counts in sample j for gene i, and
 
and are the 
mean and the variance of the distribution. Since in practice, and  are unknown, 
they are estimated from the data. Since RNA-Seq experiments usually have only a small 
number of replicates, DESeq estimates the gene expression variance between replicates 
by pooling genes with similar expression levels to enhance the variance estimation. 
DESeq estimates the mean  as: 
        (2) 
where  is a condition-dependent per-gene parameter, which is proportional to the 
expected value of the unknown true concentration of fragments from gene i under the 
experimental condition  for sample j, and  is the sampling depth of sample j. 
The variance  is the sum of a shot noise (technical variation) and a raw variance 
(biological variation):  
         (3) 
The shot noise is assumed to be Poisson distributed. Thus the variance equals the mean 
. The per-gene raw variance parameter  is a smooth function of : 
       (4) 
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Equation (4) is used to pool the data from genes with expression levels similar to gene i 
and to estimate the variance. 
After fitting data to the model, DESeq weighs the evidence in the data for 
differential expression. Suppose that there are mA replicates in condition A and mB 
replicates in condition B. For each gene i, DESeq tests the null hypothesis qiA=qiB, where 
qiA is the expression strength parameter (see equation (2)) for the samples in condition A, 
and qiB for condition B. The total counts in each condition are defined as follows: 
     (5) 
Then the overall sum is 
         (6) 
Anders and Huber (2010) showed that, under the null hypothesis, the probabilities of the 
events  and  for any given pair of numbers a and b, denoted as p(a,b), 
can be calculated. The P value of a pair of observed count sums ( ) is calculated 
as the sum of all the probabilities less or equal to p( ) given the overall sum as 
:  
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When no replicates are available, DESeq treats gene expressions between two 
experimental conditions as replicates (method=“blind”). In this case, the determination of 
differentially expressed genes will be very conservative 
Anders and Huber (2010) tested DESeq on the simulated read-counts generated 
from a negative binomial model and also on several real RNA-Seq datasets. They 
reported that DESeq controlled type-I error properly where the observed type-I error rate 
is at or lower than the DESeq claimed type-I error rate. They also compared DESeq with 
edgeR (described next). They showed that DESeq and edgeR both controlled type-I error 
well. DESeq produced more balanced results. DESeq reported a similar level of 
differentially expressed genes for both lowly and highly expressed genes, whereas edgeR 
reported more differentially expressed genes for lowly expressed genes and less 
differentially expressed genes for highly expressed genes. 
 
1.4.2 edgeR 
 
edgeR (Robinson, et al., 2010) is another parametric statistics method, which is 
also based on a negative binomial model. It was the first statistical method developed for 
DGE data, initially developed for “serial analysis of gene expression (SAGE)” data 
(Robinson and Smyth, 2008). The model formulation is very similar to that of DESeq. 
When estimating variances, DESeq and edgeR both borrow information between genes 
but in different ways. edgeR estimates the gene-wise variance or dispersion by 
conditional maximum likelihood conditioning on the total count for that gene (Smyth and 
Verbyla, 1996). It shrinks the dispersions towards a consensus value using an empirical 
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Bayes procedure (Robinson and Smyth, 2007). Differential expression is assessed by 
using an exact test similar to that of DESeq with modification for over-dispersed data for 
each gene. edgeR requires each condition having at least one replicate for input data. 
One substantial difference between DESeq and edgeR is that, in their variance 
estimation, edgeR estimates a single common dispersion parameter for all genes, whereas 
DESeq estimates the variance using a more flexible, mean-dependent local regression. 
edgeR has the option to estimate per-gene empirical variance, which, as Anders and 
Huber (2010) pointed out, has little effect on the result; results are similar to those 
obtained using the common dispersion option. 
 
1.4.3 Cufflinks/Cuffdiff 
 
Cufflinks (v2.0.1, updated in June, 2012) (Trapnell, et al., 2012; Trapnell, et al., 
2010) takes the aligned paired-end, as well as single-end, cDNA fragment sequences as 
input. It takes advantage of spliced alignments, which allows large gaps in the alignment, 
produced by, e.g., TopHat (Trapnell, et al., 2009). It then assigns the fragments or short 
reads to different isoforms through following steps: 1) identifying short reads that must 
have originated from distinct spliced isoforms (mutually incompatible fragments), 2) 
assembling isoforms based on the mutually incompatible fragments, and 3) assigning 
compatible fragments to isoforms and estimating the isoform abundance that best 
explains the observed fragments (thus Cufflinks can align short reads that can be mapped 
to multiple isoforms). The expression estimation can be further improved by correcting 
for positional and sequence-specific biases. With positional bias, fragments (short reads) 
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are preferentially located towards either the beginning or the end of transcripts. Some 
features of sequences also affect their probability of being selected for sequencing. 
Cufflinks incorporates the method described by Roberts et al. (2011) to correct these 
biases. 
Cufflinks includes a program, Cuffdiff, for testing differentially expressed genes. 
Cuffdiff uses very similar procedure to that of DESeq. It estimates the variance based on 
a negative binomial model but uses t-test to calculate the test statistics instead. When no 
replicates are available, Cuffdiff treats two experimental conditions as if they were 
replicates just like DESeq. A unique property of Cuffdiff is that, with Cufflinks’ ability 
for assigning read counts to multiple isoforms as mentioned above, it can evaluate 
expression at the transcript level. Cuffdiff uses a beta negative binomial model (a mixture 
of several negative binomial distributions) to estimate the variance of the count data of 
transcripts to include the uncertainty of assigning short reads to individual transcripts. 
 
1.4.4 baySeq 
  
baySeq (Hardcastle and Kelly, 2010) is also a parametric statistics method using a 
negative binomial model. baySeq takes a Bayesian approach where it assumes that non-
differentially expressed genes should possess the same prior distribution on the 
underlying parameters across conditions (a model groups samples across conditions 
together), whereas differentially expressed genes should possess different parameters for 
prior distributions (a model separates different conditions). It compares the posterior 
probability of the observed data given the model that groups samples across conditions 
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together (non-differentially expressed) with the posterior probability of the observed data 
given the model that separates samples between conditions (differentially expressed). 
One of the advantages of baySeq is that it enables the analysis of experimental designs 
with multiple groups (more than two conditions). baySeq requires replicates in each 
condition for input data.  
The authors compared baySeq with DESeq and edgeR on simulated count data 
generated from a negative binomial model and real datasets. They showed that baySeq 
performed at least as well as or better (more sensitive at discovering differentially 
expressed genes at the same false discovery rate) than other methods in general. baySeq 
performed especially better when the dispersion of data was constant, the proportion of 
differentially expressed genes was high, or the differential expression was unidirectional 
(all differentially expressed genes are either over-expressed or under-expressed). 
 
1.4.5 BitSeq 
 
BitSeq (Glaus, et al., 2012) is a recently developed method based on a Bayesian 
approach. It utilizes the short-read mapping data where multiple-location information is 
available (using a program, such as Bowtie). Then, as with Cufflinks, it attempts to 
estimate transcript expression levels incorporating possibilities of having isoforms. 
BitSeq, unlike Cufflinks, estimates the distribution of transcript expression levels based 
on a probabilistic model of the read generation process and a Markov chain Monte Carlo 
(MCMC) algorithm. BitSeq estimates the variance in the transcript expression based on a 
hierarchical log-normal model and determines the probability of differential expression 
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by Bayesian model averaging. BitSeq also requires replicates for each condition for input 
data. Compared with Cufflinks/Cuffdiff, DESeq, edgeR, and baySeq, the authors showed 
that, overall, BitSeq performed slightly better than baySeq, followed by DESeq and 
edgeR, and lastly Cufflinks/Cuffdiff.  
 
1.4.6 Two-Stage Poisson Model (TSPM) 
 
TSPM (Auer and Doerge, 2011) is another parametric statistics method. A unique 
feature of this method from aforementioned parametric methods is that it assumes that 
not all gene expressions are overly dispersed across samples. Therefore, the first stage of 
this method is to determine which gene-counts follow an over-dispersed Poisson model 
and which ones follow a simple Poisson model. It then applies a different likelihood ratio 
test for differential gene calling separately on the over-dispersed group and on the non-
overdispersed group.  
The authors compared their method with edgeR. TSPM performed better than 
edgeR when the data were derived from a simple Poisson distribution, but less sensitive 
when the data had an over-dispersed distribution. TSPM was not recommended if only a 
small number of replicates are available. TSPM requires replicates in each condition for 
input data.  
Kvam et al. (2012) later compared DESeq, edgeR, and baySeq with TSPM 
methods on simulated data under various scenarios, e.g., using 2 or 4 replicates, and 
using a Poisson or negative binomial model to generate count data. They reported a 
congruous result with previously mentioned comparison results; baySeq performed 
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slightly better than DESeq and edgeR in general, and TSPM performed the poorest 
especially when only a few replicates were available. 
 
1.4.7 NOISeq 
 
NOISeq (Tarazona, et al., 2011), in contrast to aforementioned methods, is a non-
parametric statistics method. Several normalization methods for the raw read counts are 
implemented with NOISeq. It includes: the number of read counts per million reads, 
RPKM (Mortazavi, et al., 2008), TMM (Robinson and Oshlack, 2010), and UQUA 
(Bullard, et al., 2010). "Trimmed mean of M-values" (TMM) calculates a normalization 
factor based on a weighted average expression ratio of all genes after removing extremely 
high and low counts data. UQUA calculates scaling factors based on per-lane upper-
quartile (75th percentile) of all the gene counts excluding those that have zero counts for 
all lanes. 
After normalization, it calculates the log-ratio (M) and the absolute value (D) of 
difference. Let be the mean or median of the expression of gene i of all replicates in an 
experimental condition g (g =1 or 2). The statistics M and D for gene i are defined as: 
       (8)
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x
i
g
)(
2
1
2log
x
xM i
i
i
=
xxD iii 21−=
22 
 
 
 
These statistics collect the information on fold-change (M) as well as the absolute 
difference (D), which compensates the unstable behavior of M at low expression values. 
The probability of a gene being differentially expressed is the probability that both |M| 
and D are greater than the noise |M*| and D*, . M* and D* 
probability distributions are empirically computed by comparing gene expression counts 
between each pair of replicates within the same condition. The odds of differential 
expression to non-differential expression are calculated as:  
       (10) 
For example, if the odds value is 4:1, the probability of differential expression is 
equivalent to 0.8. We call this probability as PNOI in this thesis. 
When no replicates are available, NOISeq simulates replicates based on a 
multinomial distribution for read counts with parameters n (the number of replicates to be 
simulated), pnr (the number of the total reads for each replicate to be simulated expressed 
in a percentage of the total reads of the available sample), and v (the variability in the 
total read numbers of the simulated samples). 
The authors compared NOISeq with several other methods including DESeq, 
edgeR, baySeq, and Fisher’s Exact Test (FET). For both simulated count data and real 
datasets, they showed that NOISeq performed comparable to or better than other 
methods. While NOISeq found slightly fewer truly differentially expressed genes 
compared to other methods, the sensitivity of discovering differentially expressed genes 
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by NOISeq was less dependent on the sequencing depth. The sensitivity of other methods 
increased with increasing sequencing depth resulting discovering more true positives. 
However, this was at the cost of having significantly more false positives compared to 
NOISeq. 
 
1.5 Objectives of This Study 
 
The simulated count data used in all previously mentioned comparative studies 
except for the study by Glaus et al. (2012) were directly simulated from a Poisson or a 
negative binomial model. However, in the real RNA-Seq analysis, some short reads can 
be mapped to more than one gene. Such non-uniquely mapped short reads are usually 
discarded and are not counted. This practice could affect the relationship between 
expected gene expression levels and the actual read counts obtained. One objective of this 
study is to include the effect of uncertainty in short-read mapping, therefore simulation 
was done following the RNA-Seq sequencing process and data analysis procedure step-
by-step. 
Another focus of this study different from others is that we compared the 
consistency and performance (sensitivity, FDR, precision and recall) of methods when no 
replicates were available. Although it is important and highly recommended to have 
biological replicates, in practice, the majority of RNA-Seq experiments include no or 
very few replicates. By testing the method performance with and without replicates, we 
examined if these methods could recover any meaningful results even when no replicates 
were included.  
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Based on multiple simulated and real datasets, we compared the performance of a 
parametric, DESeq, and a non-parametric, NOISeq, differential gene-calling methods.  
Finally, instead of choosing one method to analyze all kinds of data, we attempted 
to develop strategies regarding how to better apply these methods or combine their results 
based on the characteristics of the data. 
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2 Materials and Methods 
 
2.1 RNA-Seq Simulation 
 
2.1.1 Overall process of the simulation 
 
Simulated read-count data have been often used for testing performance of 
differential gene-calling methods (e.g., Auer and Doerge, 2011; Glaus, et al., 2012; 
Hardcastle and Kelly, 2010; Kvam, et al., 2012). In these studies, except for Glaus et al. 
(2012), count data were simulated from a defined distribution given the expected 
expression level of each gene in each condition. However, such simulation studies cannot 
incorporate uncertainties generated during the actual RNA-Seq studies. For example, it is 
a common practice in RNA-Seq analysis to only consider short reads that can be uniquely 
mapped to the reference sequences and discard the rest that maps multiple genomic 
locations or multiple transcripts. This practice may affect the relationship between the 
expected expression level and the actual count data obtained, which may cause the count 
data not following the defined distribution. In order to examine how discarding non-
uniquely mapped reads affects the results of RNA-Seq analysis, instead of only 
simulating the count data, we simulated the entire RNA-Seq process step by step. The 
overall simulation process is summarized in Figure 1. Each process is described next. 
(1) We used the consolidated set of protein-coding sequences (CDS) gathered from the 
mouse genome as our transcriptome (see Supplementary Material section S3 for the 
description of the consolidated mouse CDS set). It included 26,017 transcripts after 
excluding alternative splicing forms. Note that the terms “gene”, “transcript”, and 
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“CDS” are used interchangeably in this thesis. They all mean the sequences that are 
used for generating short reads and used as the references to be mapped by short 
reads subsequently. 
(2) Each gene was randomly assigned an expression level from a Gamma distribution 
(described in section 2.1.2). 
(3) Short reads with their length of 36bp were generated from each gene starting at 
random positions on that gene. Note that no errors (sequencing errors) were 
introduced in this process. The number of short reads generated for each gene was set 
to be proportional to the expression level and the length of the gene (described in 
section 2.1.3). The script that generated the starting positions of short reads can be 
found in Supplementary Material section S1. 
(4) Short reads generated were mapped back to the mouse reference sequences (our 
consolidated CDS dataset) by using SOAP2 (Li, et al., 2009) allowing 2 mismatches. 
We chose SOAP2 for its good performance reported in Ruffalo et al. (2011) as 
described in section1.2. Following the common practice, we only considered short 
reads that can be uniquely mapped back to the reference sequences using the option 
“–r 0”. In this setting, short reads that were mapped more than one location were 
discarded.  
(5) These steps were repeated for each replicate of each experimental condition. 
(6) Finally, the number of short reads mapped to each gene was used as the count input 
for differential gene expression analysis. 
27 
 
 
 
 
Figure 1: Workflow of data simulation.  
 
2.1.2 Modeling gene expressions 
 
The expression level of each gene at the control condition was assigned randomly 
from a Gamma distribution with the shape parameter 0.15 and the scale parameter 1160. 
The parameters were chosen to produce a distribution that was similar to the distributions 
of our real RNA-Seq datasets (described in sections 2.4 and 2.5). Figure 2 shows the 
distribution of gene expression (read count) of a real mouse dataset. Figure 3 shows the 
distribution of our simulated gene expression (read count) generated based on the above 
Gamma distribution. 
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Figure 2: Distribution of the read counts obtained from the real mouse 
RNA-Seq dataset.  
 
 
Figure 3: Distribution of the read count generated in our simulated 
RNA-Seq dataset. 
 
Our simulation strategy is summarized in Table 1. Assuming that most genes are 
not differentially expressed, we assigned 10% of genes (type A) to be “over-expressed” 
and another 10% (type B) to be “under-expressed” in the experimental condition. For 
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both over- and under-expressed genes, the fold-changes were chosen randomly from 1.1 - 
5.0. The remaining 80% of the genes (type C) were considered to have no difference in 
expected expression levels between the control and experimental conditions. Since RNA-
Seq experiments often include only a few replicates, we included only two replicates in 
each of the experimental (“Exp1” and "Exp2") and control (“Ctr1” and "Ctr2") 
conditions.  
Another set of data was also simulated for testing experiments without replicates 
(one replicate in experimental condition and one replicate in control condition).  
 
Table 1: Simulation strategy used in this study. 
Gene 
types 
Number of 
Genes 
(26,017)a 
Gene expression levelsb 
Exp1 Exp2 Ctr1 Ctr2 
A 2,602 Over Over Normal Normal 
B 2,602 Under Under Normal Normal 
C 20,183 Normal Normal Normal Normal 
aTotal number of genes are shown in parentheses. 
b
“Over”: over-expressed, “Under”: under-expressed, and “Normal”: no-differential expression. 
 
2.1.3 Modeling technical and biological variations 
 
The biological variation between replicates within each condition group was 
modeled by a Gamma distribution. Two datasets were generated with different levels of 
variations. The dataset with a moderate variation had 0.33 of the coefficient of variation 
(CV) modeling after the Chlamydomonas reinhardtii dataset described in section 2.4.2. 
The large variation dataset had 0.67 of CV modeling the Acyrthosiphon pisum dataset 
described also in section 2.4.2. For gene I, its expression level is expressed as:  
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       (11) 
where ki is the shape parameter and θi is the scale parameter of the Gamma distribution. 
The technical variation was modeled by a Poisson distribution. Thus the expression level 
of gene i, Ei, after considering both biological and technical variations can be expressed 
as: 
       (12) 
The number of short reads generated from each gene was assumed to be proportional to 
the expression level and the length of the gene to mimic the real RNA-Seq process: 
       (13) 
where Ni is the number of short reads generated for gene I, Li is the length of gene i, and c 
is a constant to make desired amount of total reads in the experiment. We chose a value 
for c to generate the approximate total of 23 million short reads for each replicate.  
 
2.2 Differential Gene Calling Methods Compared 
 
One of our focuses in this study was to examine how different differential gene-
calling methods perform when there was no replicate as it is usually the case in many 
RNA-Seq experiments. Based on this focus, we chose a popular parametric statistics 
method DESeq (version 1.2.1) and a relatively newly introduced non-parametric statistics 
method NOISeq (R script downloaded on Feb 21, 2012 from 
http://bioinfo.cipf.es/noiseq/doku.php?id=downloads). While DESeq, edgeR, and baySeq 
),(~ θλ iii kGamma
)(~ λ ii PoisE
LEN iii c ××=
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are all based on negative binomial models, DESeq can handle experimental data without 
replicates with a straightforward option. The recent version of Cuffdiff and BitSeq were 
released at the time of writing; thus they were not included in the study. As mentioned 
before, Auer and Doerge (2011) reported that TSPM does not perform well when the 
number of replicates is small. TSPM also requires replicates. NOISeq represents a 
completely different approach (non-parametric) and can handle experimental data 
without replicates.  
When testing the performance of each method without replicates, for DESeq, the 
option “method” for variance estimation was set to “blind”. For NOISeq, we used the 
recommended parameter values n=5 and pnr=0.2, but for the parameter v, we used 0.2. 
This value was chosen since it produced best results for preliminary analysis. We used 
the default parameter values for DESeq and NOISeq when replicates were available. 
DESeq takes raw count data as input. We used RPKM as the normalization method for 
NOISeq input data. 
 
2.3 Test Statistics 
 
In our simulations, as shown in Table 1, type-A and -B genes were set to be 
differentially expressed (“actual positives”), and type-C genes were set to be non-
differentially expressed (“actual negatives”). We compared the list of these genes with 
those determined to be differentially expressed by DESeq and NOISeq at various 
thresholds. Results were classified as follows: 
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• True Positive (TP): genes set to be differentially expressed and called as 
differentially expressed by the method, 
• True Negative (TN): genes set to be non-differentially expressed and not called as 
differentially expressed by the method, 
• False Positive (FP): genes set to be non-differentially expressed but called as 
differentially expressed by the method, and 
• False Negative (FN): genes set to be differentially expressed but not called as 
differentially expressed by the method. 
The performance of the methods was evaluated as follows: 
      (14) 
    (15) 
  Precision = 1 – FDR =      (16) 
  Recall = Sensitivity =      (17) 
Equation (15) is used to calculate the empirical false discovery rate from the observed 
data. For simplicity, we call it as “False Discovery Rate” or FDR. 
 
2.4 Tests using the real RNA-Seq data 
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We also tested DESeq and NOISeq on three sets of real RNA-Seq data. Human 
embryonic kidney and Ramos B cells data were published by Sultan et al. (2008). Two 
unpublished RNA-Seq datasets were by courtesy of our collaborators: a green alga 
Chlamydomonas reinhardtii dataset (Cerutti et al., in preparation) and a pea aphid 
Acyrthosiphon pisum dataset (Brisson et al., unpublished). 
 
2.4.1 Sultan et al.’s dataset 
 
Sultan et al. (2008) performed differential gene expression analysis between 
human embryonic kidney- and Ramos B-cell lines using both RNA-Seq and microarray 
experiments. We extracted the short-read count data for 13,118 genes from their RNA-
Seq study considering only the hits on the exons (total read numbers ranging from around 
5 to 7 millions) (data obtained from their supplemental material Table S2). Their 
experiments included two biological replicates. However, these data were combined in 
their study due to high correlation between replicates within each cell line. In their 
analysis, they only focused on genes that were expressed in both microarray and RNA-
Seq platforms. Genes with detection score (defined as the rank of the probe bead signal 
relatively to the negative control bead signals divided by the number of negative controls 
on the chip field) greater than or equal to 0.95 in microarray experiment and at least 5 hits 
in merged data in both conditions in RNA-Seq experiment were considered expressed 
(7043 genes). Then they applied t-test to find differentially expressed genes. We followed 
their procedure and analyzed their RNA-Seq data (7043 genes) using both DESeq and 
NOISeq as if the data were without replicates due to the merge of the data. The accuracy 
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of these methods were tested against the results obtained by Sultan et al. based on their 
microarray analysis (their supplemental material Table S4; q-value = 0.01 as the cutoff) 
for the same set of genes. We considered the microarray results as bases of our 
comparison, defining the “actual” positives and negatives. Then the precision and recall 
were calculated following the equations (16) and (17). 
 
2.4.2 Chlamydomonas and pea aphid datasets 
 
The Clamydomonas dataset compared the expression of 16,865 C. reinhardtii 
genes between the control and the nitrogen-starvation experiment (144-hour time point) 
(Cerutti et al., in preparation). Each condition included 2 replicates (total read numbers 
ranging from around 20 to 30 million). As mentioned before, this dataset had a moderate 
level of variation (0.33 of CV). The pea aphid (A. pisum) dataset compared 35,884 genes 
between the control and solitary conditions (8-hour time point) (Brisson et al., 
unpublished). For this dataset, 3 replicates were included for each condition (total read 
numbers ranging from around 2 to 3 million). The level of variation was twice larger than 
that of the Clamydomonas dataset (0.67 of CV).  
We used these datasets to test “consistency” in the results obtained by DESeq and 
NOISeq between when replicates were available and not available. Differentially 
expressed genes were first identified using all replicates. These results were used as the 
“standards” for the comparative purpose. We next analyzed the RNA-Seq data assuming 
no replicate. Then the precision and recall were calculated following the equations (16) 
and (17). Since there are multiple replicates for both control and experimental conditions, 
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we took the average statistics from all pairwise comparisons and reported the “average 
precision” and the “average recall”. 
For example, suppose that both control and experimental conditions have two 
replicates: Exp1 and Exp2, and Ctr1 and Ctr2. Suppose further that using one of the 
methods (e.g., DESeq), we find 400 differentially expressed genes considering all 
replicates. These 400 genes are considered to be "actual positives". If 80 differentially 
expressed genes are identified using the comparison of “Exp1 vs. Ctr1” (without 
considering replicate) and 20 of them are overlapped with the 400 "actual positive", the 
precision from this “Exp1 vs. Ctr1” comparison is calculated as 20/80 =0.25. The recall 
from this comparison is calculated as 20/400=0.05. We repeat this procedure for all other 
no-replicate comparisons (“Exp1 vs. Ctr2”, “Exp2 vs. Ctr1”, and “Exp2 vs. Ctr2”). 
Finally, we take the average of the precisions of the total four comparisons. We calculate 
the “average recall” in a similar fashion. 
Note that these "average precision" and "average recall" were used to measure the 
consistency in the results obtained with and without having replicates. Since for these 
actual RNA-Seq data, we do not know the true positives and true negatives, these 
statistics are used by no means to indicate the accuracy of the methods. 
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3 Results and Discussion 
 
3.1 Effects of Bias on Differential Gene Calling 
 
3.1.1 Expression-level dependency 
 
We first examined if differential gene calling is dependent on gene-expression 
levels. We used the simulated dataset with the moderate variation (CV=0.33) for this 
analysis. Using ranges of thresholds, sensitivities (equation (14)) were calculated 
separately for two groups of genes: over-expressed (type A in Table 1) and under-
expressed (type B in Table 1) genes. For DESeq, q-value (FDR adjusted p-value) was 
used for the threshold. For NOISeq, PNOI (the probability of a gene being differentially 
expressed provided by NOISeq; see section 1.4.7) was used for the threshold. When both 
being used as a threshold, q-value is roughly comparable to the probability of equivalent 
expression (1- PNOI) (Kall, et al., 2008). As shown in Tables 2 and 3, we observed 
expression-level dependent results with both DESeq and NOISeq. Both methods showed 
slightly higher sensitivities for the over-expressed genes than for the under-expressed 
genes. Over-expressed genes were slightly more likely to be correctly called as 
differentially expressed than under-expressed genes. This is consistent with the results 
reported by Wu et al. (2010). 
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Table 2: Sensitivity of DESeq gene-calling and gene-expression levels. 
  q-value threshold 
Gene group 0.005 0.01 0.05 0.1 0.2 0.3 0.4 0.5 
Over-expressed 0.21 0.26 0.36 0.44 0.51 0.57 0.63 0.66 
Under-expressed 0.19 0.23 0.32 0.39 0.46 0.52 0.57 0.62 
 
Table 3: Sensitivity of NOISeq gene-calling and gene-expression levels. 
  PNOI threshold 
Gene group 0.995 0.99 0.95 0.9 0.8 0.7 0.6 0.5 
Over-expressed 0.00 0.00 0.00 0.05 0.17 0.28 0.38 0.47 
Under-expressed 0.00 0.00 0.00 0.03 0.14 0.25 0.35 0.46 
 
3.1.2 Gene-length dependency 
 
As pointed out by Oshlack and Wakefield (2009), RNA-Seq differential calling 
shows also gene-length dependency. We examined if this length-dependency was also 
present in the results calculated by DESeq and NOISeq using again our simulated dataset 
with the moderate variation. We binned the results of differential gene calling according 
to the length of the transcript sequence (100bp increment) and calculated the proportion 
of the genes being called differentially expressed for each bin. As shown in Figure 4, 
DESeq had length-dependency where longer transcripts were more likely to be called as 
differentially expressed, whereas NOISeq did not exhibit such dependency. In order to 
examine the proportion of true positives among the genes called as differentially 
expressed, in Figure 5, precisions are plotted. Precision also showed a length-dependency 
for DESeq where precision decreased with gene length. NOISeq showed a consistently 
high precision regardless the length of the gene. Figures 4 and 5 indicate that for longer 
genes, DESeq calls more genes as differentially expressed, but their results include more 
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false positives. In contrast, NOISeq calls a smaller number of genes as positives, but with 
very high accuracy, regardless of the lengths. 
 
 
Figure 4: Gene lengths and differential gene-calling. 
The transcripts are binned according to their lengths with 100bp increment. For 
each bin, the proportion of transcripts called differentially expressed by each 
method is plotted. The thresholds used are q=0.2 for DESeq and PNOI=0.8 for 
NOISeq. The same patterns were observed when different threshold values were 
used. 
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Figure 5: Gene lengths and differential gene-calling accuracy.  
The transcripts are binned according to their lengths with 100bp increment. For 
each bin, precision of calling differentially expressed genes by each method is 
plotted. The thresholds used are q=0.2 for DESeq and PNOI=0.8 for NOISeq. The 
same patterns were observed when different threshold values were used. 
  
3.2 Gene-calling Performance and Biological Variation 
 
As mentioned before (section 2.1.3), the biological variation can be quite large in 
RNA-Seq data. In order to study if and how the variation in the data affects the 
performance of differential gene calling, we analyzed two simulated datasets that 
modeled two levels of biological variation: moderate (CV= 0.33) and large (CV=0.67) 
datasets. The sensitivities and false discovery rates were calculated using the equations 
(14) and (15). 
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3.2.1 False discovery rate (FDR) control 
 
DESeq calculates a q-value (FDR adjusted p-value) for each gene and uses it as 
the threshold to identify differentially expressed genes. If the method controls FDR well, 
the q-value threshold should equal to or greater than the observed FDRs. As shown in 
Figure 6, DESeq controlled FDRs more reliably when the biological variation was 
moderate compared to when the biological variation was large. With the large variation, 
observed FDRs were significantly larger than reported q-values especially for q-values 
smaller than 0.2. This result is consistent with the one obtained by Kvam et al.(2012). 
FDR was not controlled in their "Simulation 4" where variation was large.  
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Figure 6: False discovery rate observed for DESeq at different q-value 
thresholds with moderate and large biological variation. 
The black dashed-line is where the observed FDRs equal q-value 
thresholds.  
 
 
 
Figure 7: False discovery rate observed for NOISeq at different 1-PNOI 
thresholds with moderate and large biological variation. 
The black dashed-line is where the observed FDRs equal q-value 
thresholds. 
 
42 
 
 
 
NOISeq calculates the probability (PNOI) to identify differentially expressed genes. 
As mentioned before, we can consider 1-PNOI to be equivalent to q-value (Kall, et al., 
2008). As shown in Figure 7, although observed FDRs were consistently larger when the 
biological variation was large, NOISeq roughly controlled the FDR regardless of the 
level of variation. In fact when the variation is moderate, the observed FDRs were much 
lower than 1-PNOI values.  DESeq and NOISeq both had much larger false discovery rates 
when the biological variation was large.  
 
3.2.2 Effect of biological variation on differential gene-calling 
 
Next we compared the effect of biological variation on the performance of 
differential gene-calling by DESeq and NOISeq. As shown in Figure 8, with the 
moderate variation, DESeq performed much better (higher sensitivity with the same FDR) 
with the q-value threshold greater than 0.005 as indicated by the large gap between the 
curves. NOISeq performed better with the PNOI threshold greater than 0.8. With the large 
variation, as shown with Figure 9, DESeq performed better with the q-value threshold 
greater than 0.3 and NOISeq performed better with the PNOI threshold greater than ~0.7. 
Both DESeq and NOISeq showed that with the same q-value or PNOI thresholds, FDRs 
were higher when the biological variation was larger. 
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  Figure 8: Gene-calling performance on the moderate dataset. 
Sensitivities are plotted against the false discovery rates calculated from the 
results obtained by DESeq (blue circles) and NOISeq (red squares) for the 
dataset with the moderate variation. DESeq and PNOI thresholds used are shown 
for some data points. 
 
 
   
  Figure 9: Gene-calling performance on the large dataset. 
Sensitivities are plotted against the false discovery rates calculated from the 
results obtained by DESeq (blue circles) and NOISeq (red squares) for the 
dataset with the large variation. DESeq and PNOI thresholds used are shown for 
some data points. 
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3.2.3 Effect of uncertain read-mapping 
 
In our simulation process, read-mapping uncertainty was naturally incorporated. 
Around 90% of short reads were mapped back to the reference sequences. The 10% reads 
that were not mapped to the reference were the reads that were mapped to multiple 
locations on the reference. We suppose more reads would be discarded if sequencing 
errors were introduced and less reads would be discarded if reads were longer. We 
compared the results obtained by DESeq and NOISeq using data from two simulation 
processes: simulating the entire RNA-Seq process and simulating count data directly as 
many previous studies have done. As shown in Tables 4-7, both DESeq and NOISeq 
showed slightly better performance (larger or at least the same sensitivity) when count 
data were simulated directly compared to when simulations were done following the 
entire process. Uncertainty in read mapping process, therefore, affected the performance 
of the program, although the differences shown with our examples were small.  
Table 4: Sensitivities and FDRs observed by DESeq using two simulation processes on 
moderate-variation data. 
  q-value threshold 
0.001a 0.005 0.01 0.05 0.1 0.2 
Entire process 0.08 (0.02) 0.14 (0.03) 0.17 (0.03) 0.24 (0.08) 0.28 (0.13) 0.36 (0.20) 
Direct count 0.09 (0.02) 0.15 (0.02) 0.18 (0.03) 0.26 (0.08) 0.31 (0.12) 0.36 (0.20) 
aValues in parentheses are FDRs. 
 
Table 5: Sensitivities and FDRs observed by NOISeq using two simulation processes 
on moderate-variation data. 
  PNOI-threshold 
0.999a 0.995 0.99 0.95 0.9 0.8 
Entire process 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.001 (0.00) 0.03 (0.00) 0.108 (0.03) 
Direct count 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.001 (0.00) 0.03 (0.00) 0.114 (0.03) 
aValues in parentheses are FDRs. 
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Table 6: Sensitivities and FDRs observed by DESeq using two simulation processes on 
large-variation data. 
  q-value threshold 
0.001 0.005 0.01 0.05 0.1 0.2 
Entire process 0.00 (0.00) 0.00 (0.00) 0.001 (0.36) 0.005 (0.28) 0.01 (0.27) 0.03 (0.27) 
Direct count 0.00 (0.00) 0.00 (0.50) 0.001 (0.25) 0.005 (0.29) 0.01 (0.27) 0.04 (0.26) 
aValues in parentheses are FDRs. 
 
Table 7: Sensitivities and FDRs observed by NOISeq using two simulation processes 
on large-variation data. 
  PNOI-threshold 
0.999 0.995 0.99 0.95 0.9 0.8 
Entire 
process 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.002 (0.10) 0.01 (0.10) 0.039 (0.17) 
Direct count 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) 0.002 (0.08) 0.01 (0.12) 0.042 (0.16) 
aValues in parentheses are FDRs. 
 
 
3.2.4 Effect of replications on differential gene-calling 
 
We next examined the performance of DESeq and NOISeq on the simulated 
datasets where no replicates were used. Compared to the results shown in Figures 8 and 
9, when no replicates were available, as shown in Figures 10 and 11, the overall accuracy 
for both methods decreased dramatically as expected and the false discovery rates were 
very large at all thresholds. DESeq found hardly any truly differentially expressed genes 
when no replicates were available. For example, while DESeq had sensitivity about 0.25 
in Figure 8 at the q-value threshold of 0.05, in Figure 10, sensitivity was 0 at the same 
threshold. NOISeq still found truly differentially expressed genes however at a cost of 
having many false positives. For example, NOISeq had 0.1 sensitivity and FDR = 0.03 at 
the PNOI = 0.8 threshold in Figure 8, but 0.17 sensitivity and FDR = 0.23 in Figure 10 at 
the same threshold. DESeq was conservative in calling differentially expressed genes 
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when no replicates were available, whereas NOISeq was much more aggressive. Similar 
to when replicates are available, when variation was large, both methods performed 
worse as shown in Figure 11. Based on the results, it is highly recommended to have 
replicates in RNA-Seq experiments. However, if no replicates are available, NOISeq may 
serve better as a starting point of analysis. 
 
Figure 10: Gene-calling performance on the moderate-variation dataset 
and with no replicate. 
Sensitivities are plotted against the false discovery rates calculated from the results 
obtained by DESeq (blue circles) and NOISeq (red squares) for the dataset with the 
moderate variation.  
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Figure 11: Gene-calling performance on the large-variation dataset and 
with no replicate. 
Sensitivities are plotted against the false discovery rates calculated from the results 
obtained by DESeq (blue circles) and NOISeq (red squares) for the dataset with the 
large variation. 
 
 
3.2.5 Combining results of DESeq and NOISeq to improve differential gene-calling 
 
We next examined if we could improve the accuracy in identifying differentially 
expressed genes by combining the results obtained by DESeq and NOISeq. We tested 
ranges of combinations of thresholds (q-value for DESeq and PNOI for NOISeq). At each 
threshold combination, positives (differentially expressed genes) were identified for those 
called by both methods (i.e., by taking the intersection of both results). In order to find 
the best performing combination, we calculated the sensitivity to FDR ratio for the result 
at each combination. The results of the entire combination analysis are shown in 
Supplementary Material section S2. Results are summarized in Tables 8 and 9 below. For 
the moderate-variation data, as shown in Table 8, when using DESeq and NOISeq 
individually, the highest sensitivity to FDR ratios were 5.67 and 1.04, respectively.  
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Using the combination strategy, the combination with 0.005 q-value threshold for DESeq 
and 0.6 PNOI threshold for NOISeq generated the highest sensitivity to FDR ratio, 60. 
This is significantly better than individual results. Figure 12 also shows that the 
combination strategy can improve the performance by lowering FDRs significantly. For 
the large-variation data, as shown in Table 9, combination with 0.4 q-value threshold for 
DESeq and 0.5 PNOI threshold for NOISeq generated the highest sensitivity to FDR ratio 
among all combinations. Although using NOISeq with 0.5 PNOI generated 0.38 sensitivity 
to FDR ratio, the FDR is too high (0.56, see Table S2) to use in practice. Therefore, we 
still think using the combination strategy is a better choice. However, sensitivities and 
ratios are all very low with such large variation. As shown in Figure 13, combination 
strategy can still improve the performance especially at lower FDRs. Therefore, it is 
possible to produce better result by combining two methods using appropriate threshold 
combinations: e.g., (q, PNOI) = (0.005, 0.6) for moderate-variation data, or (q, PNOI) = (0.4, 
0.5) for large-variation data. We also tried combined strategy with no-replicate data. 
However, combined strategy did not improve the accuracy of calling differentially 
expressed genes when no replicates were available. 
 
Table 8: Combination strategy on moderate-variation data. 
  Threshold combination 
q-value 
0.001 
(4)a 
0.005 
(4.67) 
0.01 
(5.67) 
0.05 
(3) 
0.1 
(2.15) 
0.2 
(1.7) 
PNOI 
0.6 
(1.04) 
0.6 
(1.04) 
0.6 
(1.04) 
0.6 
(1.04) 
0.5 
(0.84) 
0.9 
(-) 
Sensitivity 0.075 0.12 0.147 0.192 0.247 0.028 
FDR 0.003 0.002 0.003 0.024 0.045 0.007 
Sensitivity/FDR 25 60 49 8 5.49 4 
aValue in parenthesis is the sensitivity to FDR ratio when using the corresponding method along. 
‘-‘ indicates that the sensitivity or FDR is 0. 
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Table 9: Combination strategy on large-variation data. 
  Threshold combination 
q-value 
0.05 
(0.02)a 
0.1 
(0.04) 
0.2 
(0.11) 
0.3 
(0.24) 
0.4 
(0.31) 
0.5 
(0.36) 
PNOI 
0.5 
(0.38) 
0.5 
(0.38) 
0.5 
(0.38) 
0.5 
(0.38) 
0.5 
(0.38) 
0.5 
(0.38) 
Sensitivity 0.003 0.009 0.028 0.057 0.089 0.115 
FDR 0.053 0.113 0.131 0.174 0.238 0.321 
Sensitivity/FDR 0.06 0.08 0.21 0.33 0.37 0.36 
aValue in parenthesis is the sensitivity to FDR ratio when using the corresponding method alone. 
 
 
 
Figure 12: Performance of combination strategy on the moderate-
variation dataset. 
Sensitivities are plotted against the false discovery rates calculated from the 
results obtained by DESeq (blue circles), NOISeq (red squares) and Combined 
method (black diamond). Combinations of q-value threshold and PNOI threshold 
used are shown for some data points. 
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Figure 13: Performance of combination strategy on the large-variation 
dataset. 
Sensitivities are plotted against the false discovery rates calculated from the 
results obtained by DESeq (blue circles), NOISeq (red squares) and Combined 
method (black diamond). Combinations of q-value threshold and PNOI threshold 
used are shown for some data points. 
 
 
3.3 Performance Analysis on the Real Data 
 
3.3.1 Comparing the results between RNA-Seq and microarray analyses 
 
We tested the performance of DESeq and NOISeq on the real RNA-Seq datasets 
published by Sultan et al. (2008). Since both microarray and RNA-Seq data on the same 
sample are available, we considered the microarray result as the reference defining 
“actual positives” (differentially expressed) and “actual negatives” (not differentially 
expressed). We also only considered the “expressed” genes (7043) following their 
definition. Precision and recall were calculated as described in section 2.4.1. 
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As shown in Tables 10 and 11, both methods had almost 80% or higher precision. 
However, their recall values were very low (lower than 0.03 for DESeq and lower than 
0.27 for NOISeq). At the most stringent thresholds (q-value threshold = 0.001 and PNOI 
threshold = 0.999), DESeq showed higher precision but lower recall than those of 
NOISeq. At less stringent thresholds (0.005 ≤ q-value threshold ≤ 0.05 and 0.995 ≥ PNOI 
threshold ≥ 0.95), NOISeq showed both higher precision and recall. At more relaxed 
thresholds (0.1 ≤ q-value threshold ≤ 0.2 and 0.9 ≥ PNOI threshold ≥ 0.8), NOISeq showed 
lower precision but much higher recall. It should be noted that although replicates in 
RNA-Seq data by Sultan et al. (2008) were combined, their data had a low level of 
variation (Pearson’s correlation coefficient was 0.99 for human embryonic kidney sample 
and 0.98 for B-cell sample) between original replicates. From both simulated dataset and 
real dataset analysis, NOISeq with relaxed thresholds (0.8 - 0.95) appears to be a better 
choice compared to DESeq for differential gene-calling when no replicates are available. 
 
Table 10: Performance of DESeq compared against the microarray study. 
  q-value threshold 
 0.001 0.005 0.01 0.05 0.1 0.2 
Precision 1.00 0.81 0.79 0.83 0.87 0.86 
Recall 0.001 0.005 0.007 0.015 0.02 0.03 
 
 
Table 11: Performance of NOISeq compared against the microarray study. 
  PNOI-value threshold 
 0.999 0.995 0.99 0.95 0.9 0.8 
Precision 0.91 0.85 0.86 0.84 0.82 0.76 
Recall 0.003 0.007 0.01 0.06 0.12 0.27 
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3.3.2 Consistency analysis between with and without biological replications 
 
Using the two sets of real RNA-Seq data, we tested the “consistency” in the 
results given by DESeq and NOISeq. We compared the results from DESeq and NOISeq 
using no replicate with those using replicates on the same datasets. Two datasets are: the 
Chlamydomonas datasets that have moderate variation and the pea aphid data that have 
large variation. See section 2.4.2 for more information on these datasets. The objective 
here is to see if DESeq and NOISeq can yield somewhat consistent/reliable results when 
no replicates are available. As described in section 2.4.2, we calculated the average 
precision and average recall. Note that in this section, these statistics are used to measure 
the consistency in differential gene-calling when no replicates are available compared 
against when replicates are available. They are used by no means to indicate any level of 
accuracy. 
 
Table 12: Performance consistency with DESeq on the Chlamydomonas data. 
  q-value threshold 
 0.001 0.005 0.01 0.05 0.1 0.2 
Average Precision 1.00 0.99 0.99 0.99 0.99 0.99 
Average Recall 0.03 0.04 0.05 0.07 0.07 0.08 
 
 
Table 13: Performance consistency with NOISeq on the Chlamydomonas data. 
  PNOI threshold 
 0.999 0.995 0.99 0.95 0.9 0.8 
Average Precision 0.02 0.08 0.12 0.15 0.17 0.24 
Average Recall 1.00 1.00 1.00 0.96 0.95 0.94 
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Table 14: Performance consistency with DESeq on the pea aphid data. 
  q-value threshold 
 0.001 0.005 0.01 0.05 0.1 0.2 
Average Precision 0.52 0.52 0.53 0.52 0.51 0.48 
Average Recall 0.27 0.29 0.29 0.32 0.32 0.33 
 
 
Table 15: Performance consistency with NOISeq on the pea aphid data. 
  PNOI threshold 
 0.999 0.995 0.99 0.95 0.9 0.8 
Average Precision 0.00 0.02 0.03 0.17 0.22 0.25 
Average Recall 0.00 0.33 0.33 0.38 0.39 0.43 
 
 
As shown in Table 12, DESeq was found to be very conservative in finding 
differentially expressed genes when no replicates were available. This was indicated by 
very high precision and very low recall. In other words, with no replicates, while DESeq 
found only a small number of genes as differentially expressed, many of these identified 
genes were what it would have found if there were replicates. As shown in Table 13, 
NOISeq was found to be more aggressive in finding differentially expressed genes when 
no replicates were available, indicated by relatively low precision and high recall. It 
indicated that, without replicates, NOISeq could find almost all genes that would have 
been found if there were replicates. However, it also found many genes that would not 
have been found if replicates were available (possible false positives). When the data 
included much larger variation (CV=0.67), as shown with the results with the pea aphid 
datasets in Tables 14 and 15, as expected, results obtained from single replicates were not 
consistent with those obtained when replicates were available. Interestingly, precisions of 
NOISeq do not seem to be affected by the level of variations. Thus, regardless of the 
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amount of variation, with NOISeq we expect to find the same proportion of false 
positives (inconsistently identified genes). However, the recall values were severely 
affected with the larger variation and it dropped to the level almost the same as found 
with DESeq.  
These results were consistent with what we found using simulated data in section 
3.2.4. When no replicate is available for both moderate- and large-variation datasets, 
DESeq is very conservative in finding differentially expressed genes whereas NOISeq is 
more aggressive but more error prone. 
 
3.4 Suggested Guidelines of Using DESeq and NOISeq 
 
This study clearly showed that biological variation affects significantly and 
differently how DESeq and NOISeq perform in differential gene-calling. Large variation 
will cause more false positives for both DESeq and NOISeq. We also showed that it is 
possible to improve the accuracy by combining the results of both methods. Based on the 
results we obtained in this study, following are our suggested strategies of using DESeq 
and NOISeq depending on the level of biological variation: 
(1) If the biological variation is moderate, e.g., CV 0.33, to control the FDR around 
0.05, we can take advantage of combining results by taking the intersection of 
both methods using q=0.1 threshold for DESeq and PNOI= 0.5 threshold for 
NOISeq.  
≈
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(2) If the biological variation is large, e.g., CV 0.67, it may be useful to consider a 
relaxed FDR control, e.g., around 0.2, in order to find a good number of 
differentially expressed gene candidates. We can use the combined results using q 
= 0.4 threshold for DESeq and PNOI= 0.5 threshold for NOISeq. Note that only a 
very small number of differentially expressed genes can be found in order to 
control the FDR smaller than 0.2. 
It is highly recommended to have replications in RNA-Seq experiments. As our 
results showed, when there is no replicate, DESeq finds a very small number of 
differentially expressed genes. On the contrary, NOISeq finds more candidates of 
differentially expressed genes, which, however, include a large number of false positives. 
Based on what we observed with the results on real datasets, DESeq is very conservative 
where fewer genes are identified but its results are more consistent with the results 
obtained using replicates. NOISeq is more aggressive where more genes are identified 
but its results are less consistent with the results obtained using replicates. When the 
results of DESeq and NOISeq are compared to the results of Sultan et al. (2008)'s 
microarray analysis, NOISeq performed better. Based on our no-replicate experiments, 
the recommended strategy for analyzing no-replicate datasets is to use NOISeq with PNOI 
thresholds 0.8-0.95. 
 
≈
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4 Conclusions and Future Work 
 
In this study, we presented a comparison between a parametric method DESeq 
and a non-parametric method NOISeq for differential gene-calling based on RNA-Seq 
data. Both DESeq and NOISeq performed much better on data with moderate biological 
variation than with large biological variation. They both found slightly more truly over-
expressed genes than under-expressed genes. DESeq showed length-based bias where 
longer transcripts were called more as differentially expressed, whereas NOISeq did not 
show such trend.  
Our results showed the importance of understanding the variation in the data. We 
also showed that combination strategy can be used to obtain improved differential gene-
calling. If the biological variation is moderate and if we want to control FDR around 
0.05, we can use the differentially expressed genes claimed by both programs with 0.1 q-
value threshold for DESeq and 0.5 PNOI threshold for NOISeq. If the biological variation 
is large, we need to consider a higher FDR control, e.g., 0.2 or even higher, in order to 
find a good number of differentially expressed genes. We can use the combined results 
with 0.4 q-value threshold for DESeq and 0.5 PNOI threshold for NOISeq. When no 
replicates are available, DESeq is conservative in finding differentially expressed genes, 
whereas NOISeq is aggressive. Based on the simulated data and real data analysis, we 
recommend using NOISeq with probability thresholds 0.8 ~ 0.95. 
In order to confirm our analysis of DESeq and NOISeq, for example, qRT-PCR 
confirmation results for some of the identified genes would be useful. We would like to 
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collaborate on this regard with our collaborators for further analysis of their RNA-Seq 
data. 
More different methods with more data should be tested to see if they have 
consistent performance. Especially interesting ones are those very recently developed 
RNA-Seq differential expression calling methods, e.g., new versions of 
Cufflinks/Cuffdiff (Trapnell, et al., 2012) and BitSeq (Glaus, et al., 2012). Combination 
methods should be also further explored for the most reliable results. 
It would also be interesting to consider differential expression in terms of gene 
pathways and try to find differentially expressed gene pathways in various conditions. 
We can test the performance of currently available methods of analyzing gene pathways 
using RNA-Seq data or build our own method to analyze and gain insights on the 
expression patterns on the level of gene pathways. 
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S1 The R Script Used for the Simulation  
 
We wrote the R script to generate the appropriate amount (according to the 
expression assigned) of starting positions of each transcript for producing short reads as 
shown in Figure S1. It takes the length of each transcript of a sequence file as input (input 
file has only the length for each transcript) and produces 4 sets of starting positions for 
each transcript for the entire sequence file. We then generated subsequences of length 36 
from each transcript as short reads based on these starting positions. Biological and 
technical variations are both incorporated in the script. The simulation is described in 
detail in material and methods in the main text. 
 
#Read in the length of each gene 
m<-read.table("Ref_length.txt"); 
exp1<-c(); 
exp2<-c(); 
ctr1<-c(); 
ctr2<-c(); 
#Total number of genes 
total<-26017; 
# shape and scale parameter of gamma distribution to assign expected expression for each 
gene 
shape_var<-0.15; 
scale_var<-1160; 
#biological variation parameter 
bio_var<-9; 
#max fold change allowed in experimental condition 
max_fold<-5; 
#randomize the seed 
set.seed(as.integer(as.double(Sys.time()))); 
#first 10% is differentially under-expressed genes  
for(i in 1:2602) 
{ 
   #fold chagne expected in experimental condition   
   fold<-1/(sample(11:(max_fold*10),1)/10); 
   #transcript expression level 
   level<-rgamma(1,shape_var,scale=scale_var); 
   #biological variation (constant coefficient of variation) 
   num1<-rgamma(1,bio_var,scale=level*fold/bio_var); 
   num2<-rgamma(1,bio_var,scale=level*fold/bio_var); 
   num3<-rgamma(1,bio_var,scale=level/bio_var); 
   num4<-rgamma(1,bio_var,scale=level/bio_var); 
   #technique variation assuming Poisson 
   exp1<-append(exp1,rpois(1,num1)); 
   exp2<-append(exp2,rpois(1,num2)); 
   ctr1<-append(ctr1,rpois(1,num3)); 
   ctr2<-append(ctr2,rpois(1,num4)); 
} 
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#this second 10% is differentially over expressed genes 
for(i in 2603:5204) 
{ 
   fold<-sample(11:(max_fold*10),1)/10; 
   level<-rgamma(1,shape_var,scale=scale_var); 
   num1<-rgamma(1,bio_var,scale=level*fold/bio_var); 
   num2<-rgamma(1,bio_var,scale=level*fold/bio_var); 
   num3<-rgamma(1,bio_var,scale=level/bio_var); 
   num4<-rgamma(1,bio_var,scale=level/bio_var); 
   exp1<-append(exp1,rpois(1,num1)); 
   exp2<-append(exp2,rpois(1,num2)); 
   ctr1<-append(ctr1,rpois(1,num3)); 
   ctr2<-append(ctr2,rpois(1,num4)); 
} 
#rest 80% is non-differentially expressed genes 
for(i in 5205:total) 
{ 
   level<-rgamma(1,shape_var,scale=scale_var); 
   num1<-rgamma(1,bio_var,scale=level/bio_var); 
   num2<-rgamma(1,bio_var,scale=level/bio_var); 
   num3<-rgamma(1,bio_var,scale=level/bio_var); 
   num4<-rgamma(1,bio_var,scale=level/bio_var); 
   exp1<-append(exp1,rpois(1,num1)); 
   exp2<-append(exp2,rpois(1,num2)); 
   ctr1<-append(ctr1,rpois(1,num3)); 
   ctr2<-append(ctr2,rpois(1,num4)); 
} 
 
#Now generating short reads from mouse transcripts 
#assumed short reads length 
read_length<-36; 
#initialize the length of gene that are mappable to short reads 
effe_length=0; 
sink("exp1.txt"); 
for(i in 1:total) 
{ 
   if(m[i,1]<36) 
   { 
      effe_length=0; 
   } 
   else 
   { 
      effe_length=m[i,1]-read_length; 
   } 
   cat(sample(0:effe_length,as.integer(effe_length/300*exp1[i]),replace=TRUE)); 
   cat("\n"); 
} 
sink(); 
sink("exp2.txt"); 
for(i in 1:total) 
{ 
   if(m[i,1]<36) 
   { 
      effe_length=0; 
   } 
   else 
   { 
      effe_length=m[i,1]-read_length; 
   } 
   cat(sample(0:effe_length,as.integer(effe_length/300*exp2[i]),replace=TRUE)); 
   cat("\n"); 
} 
sink(); 
sink("ctr1.txt"); 
for(i in 1:total) 
{ 
   if(m[i,1]<36) 
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   { 
      effe_length=0; 
   } 
   else 
   { 
      effe_length=m[i,1]-read_length; 
   } 
   cat(sample(0:effe_length,as.integer(effe_length/300*ctr1[i]),replace=TRUE)); 
   cat("\n"); 
} 
sink(); 
sink("ctr2.txt"); 
for(i in 1:total) 
{ 
   if(m[i,1]<36) 
   { 
      effe_length=0; 
   } 
   else 
   { 
      effe_length=m[i,1]-read_length; 
   } 
   cat(sample(0:effe_length,as.integer(effe_length/300*ctr2[i]),replace=TRUE)); 
   cat("\n"); 
} 
sink(); 
#When testing on no-replicate experiments, just use one short reads file 
#from exp and one from ctr condition. 
Figure S1: R script for generating starting positions for short reads  
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S2 Analysis of Combining DESeq and NOISeq Results with Various 
Thresholds 
  
As we described in section 3.2.5, we examined many possible combinations of 
thresholds to see if we can improve differential gene-calling performance by combining 
the results from DESeq and NOISeq (taking the intersection results). Supplemental 
Tables S1 and S2 showed the sensitivities, FDRs and sensitivity to FDR ratios from the 
combined results with all possible pairs of thresholds: DESeq q-value thresholds (1*10-20, 
1*10-10 , 0.00001, 0.00005, 0.0001, 0.0005, 0.001, 0.005, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4 and 
0.5) and NOISeq PNOI thresholds (1-1*10-20, 1-1*10-10 , 0.99999, 0.99995, 0.9999, 
0.9995, 0.999, 0.995, 0.99, 0.95, 0.9, 0.8, 0.7, 0.6 and 0.5).  
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Table S1: Analysis of combination strategy with moderate variation data.a 
    NOISeq PNOI threshold 
    
1-1*10
-20
 1-1*10
-10
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aThe result is formatted as sensitivity, FDR, sensitivity to FDR ratio. The ratio is shown in bold and blue fonts when it is larger than the highest 
ratio obtained by either DESeq or NOISeq, which is 5.67 (DESeq at q=0.01). The highest ratio is shown in red and bold fonts. 
bThe column and the row shows the statistics from using the single method. The highest ratio in each method is shown in bold fonts. 
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Table S2: Analysis of combination strategy with large variation data.a 
      NOISeq PNOI threshold 
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aThe result is formatted as sensitivity, FDR, sensitivity to FDR ratio. The ratio is shown in bold and blue fonts when it is larger than the highest 
ratio obtained by DESeq (0.36 at q=0.5). However, this is not higher than the highest ratio obtained by NOISeq, which is 0.38 (NOISeq at 
PNOI=0.5).  
bThe column and the row shows the statistics from using the single method. The highest ratio in each method is shown in bold fonts.
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S3 Development of the Consolidated Mouse Genome Annotation 
 
 Several versions of mouse genome annotations are available from different 
databases. Three prominent databases (NCBI, Ensembl, and UCSC) are listed in Table 
S3. In order to obtain a single and most inclusive, as complete as possible, annotated 
mouse genome, we decided to develop our own consolidated set of mouse protein coding 
sequences (CDS). 
 
Table S3: Three currently available mouse genome annotations.a 
Database Website Annotation Version Number of 
transcripts 
NCBI http://www.ncbi.nlm.nih.gov/ MGSCv37 27270 
Ensembl http://uswest.ensembl.org/in
dex.html 
M37.61 54948 
UCSC http://genome.ucsc.edu/ Downloaded the 
"knownGene" table of 
"NCBI37/mm9" build 
on Feb 7, 2011 
39481 
aData are available in the file “gff3.zip” found at: http://bioinfolab.unl.edu/emlab/gpcr_mouse/  
It contains “NCBI.gff3”, “Ensembl.gff3”, and “UCSC_info.txt”, each of which corresponds to 
the annotation file downloaded from NCBI, Ensembl, and UCSC, respectively. 
 
Our consolidated set of mouse protein coding sequences (CDS) was generated 
through following steps: 
Step 1: Based on the three annotations, we compared the location of CDS from each 
transcript (all coding regions on exons). If a CDS had the exact same location 
and exon-intron structure annotated by any two or all databases but named 
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differently, we retained the corresponding regions of the sequence and simply 
concatenated their entry names to make the name of the sequence in our 
consolidated set. For example, if a sequence annotated in NCBI with name 
“NM_1234” is on chromosome 1 with the coding region from position 100 
nucleotide (nt) to position 500 nt and a sequence annotated in Ensembl with 
name “ENSMUST5678” is also on chromosome 1 with its coding region from 
position 100 nt to position 500 nt and the exon-intron structure are exactly the 
same, two annotations obviously referred to the same CDS. In this case, we 
retained this CDS region of the genome and name it as 
“NM_1234|ENSMUST5678” in our consolidated set.  
Step 2: If we cannot find an exact location match, we kept all versions of the sequence as 
they were annotated in each database. For example, if the previous example had 
“NM_1234” with the coding region 100-500 nt but “ENSMUST5678” with its 
coding region 100-550 nt, we kept both versions of the CDS. In this case, 
“NM_1234” and “ENSMUST5678” became two different entries with their 
corresponding CDSs in our consolidated set.  
Step 3: For CDSs that were on not fully resolved scaffolds (no clear chromosomal 
assignment in the genome), we extracted the CDS from the scaffold and used 
BLAST (blastn) (Altschul, et al., 1990) to perform similarity search against the 
each resolved chromosome of the mouse genome. If a perfect match (100% 
identity and coverage) was found, we assumed this CDS was on the location of 
the matched chromosome, and then treated it as a CDS with the apparent position 
on the chromosome and apply steps 1 and 2 on it. 
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Step 4: We used those CDSs on unresolved scaffolds that did not have perfect matches 
after step 3 to perform BLAST (blastn) similarity search against all unresolved 
scaffolds. If a perfect match was found, we retained the CDS and concatenated 
their sequence names. For example, if a sequence named “NM_1111” was on 
“scaffold_1” and a sequence named “ENMUST2222” was on “scaffold_5”, and 
their sequences were identical, we retained the CDS and named it as 
“NM_1111|ENMUST2222” in our consolidated set.  
Step 5: We retained the CDS regions of the rest of sequences as they are annotated in 3 
databases.  
 
In essence, we extracted the CDS regions of all mouse transcripts from 3 sets of 
annotations, removed all redundant copies of CDS if it was annotated on the same 
chromosomal location in more than two databases, and kept all versions of CDS if it was 
annotated on different chromosomal locations in different databases.  
We call our consolidated mouse CDS set “Con_Mouse”. The database (in a 
FASTA format file) is available from: 
http://bioinfolab.unl.edu/emlab/gpcr_mouse/Ref_transcripts.fa 
The example entries of the Con_Mouse database are shown in Figure S2.  
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>NM_025928.2|ENSMUST00000056370|uc008pva.1 
ATGGCTGAGGTGAGCCGAGATAGCGAGGCTGCGGAAAGGGGGCCTGAGGGCTCCTCTCCGGAAGCTGTGCCA
GGGGACGCGACCATCCCCAGGGTGAAACTCCTGGACGCCATAGTAGACACTTTCCTCCAGAAGCTAGTCGCC
GACAGGAGCTACGAGAGGTTCACCACCTGCTACAAACACTTCCACCAGTTGAACCCTGAGGTGACGCAGAGG
ATCTATGACAAGTTTGTGGCTCAGTTGCAGACATCCATCCGCGAGGAAATCTCAGAAATCAAAGAGGAGGGG
AACCTAGAAGCTGTCCTGAACTCCCTGGATAAGATCATAGAAGAAGGCAGAGAGCGCGGAGAGCCAGCCTGG
CGACCCAGTGGAATCCCAGAGAAAGACCTGTGTAGTGTCATGGCACCCTACTTCCTGAAGCAACAGGATACC
CTGTGTCATCAAGTACGGAAACAGGAAGCCAAGAACCAGGAACTGGCCGACGCTGTCCTGGCCGGGCGCAGG
CAGGTGGAGGAGCTGCAGCAGCAGGTTCGGGCCCTCCAGCAAACATGGCAGGCTCTACACAGAGAGCAGAGG
GAGCTGCTGTCAGTGCTGAGGGCGCCTGAGTGA  
>ENSMUST00000150158 
ATGGAGGAACTGATACTGCAGGATGAGACCCTCCTGGAGACCATGCAGAGCTACATGGACGCCTCCCTTATA
TCCCTCATTGAGGATTTTGGAGAGAGCAGATTATCTCTGGAGGACCAGAATGAAATGTCGCTGCTCACAGCT
CTGACGGAGATCTTGGACAATGCAGATTCTGAGAACCTGTCCCCTTTTGACACCATTCCTGATTCAGAGCTG
CTCGTGTCCCCTCGGGAGAGCTCCTCTGTTGAGGTGCCTCTTGCAGACTCTCCATGGGACTTCTCTCCGCCT
CCTTTCTTGGAAACTTCTTCCCCTAAGCTGCCTAGCTGGAGACCCTCGAGACCAAGACCTCGATGGGGTCAG
TCCCCTCCTCCTCAGCAGCGCAGTGATGGGGAAGAGGAGGAGGAGGTCGCCGGTTTCAGTGGTCAGATGCTT
GCTGGC  
>NM_025868.2|ENSMUST00000053664|ENSMUST00000111665|uc008kix.1 
ATGGCTGTCCTTGCGCCTCTGATTGCTTTGGTGTACTCGGTGCCGCGGCTTTCTCGATGGCTGGCCCGACCT
TATTGCCTTCTGTCTGCTCTGCTTTCCATTGCTTTCCTCCTCGTGAGGAAACTGCCACCGATTTGCAATGGT
CTCCCCACGCAACGCGAAGATGGCAACCCGTGTGACTTTGACTGGAGAGAAGTGGAGATCCTGATGTTCCTC
AGTGCCATTGTGATGATGAAGAACCGCAGATCCATCACTGTGGAGCAACATGTAGGCAACATCTTTATGTTT
AGTAAAGTGGCCAACGCCATCCTTTTCTTCCGACTGGATATTCGAATGGGTCTGCTATACCTCACACTCTGC
ATAGTGTTCCTGATGACCTGCAAGCCCCCGCTGTACATGGGTCCTGAGTATATCAAGTACTTCAATGATAAA
ACCATTGATGAGGAGCTGGAGCGAGACAAGAGGGTCACTTGGATTGTGGAGTTCTTTGCCAACTGGTCTAAT
GATTGCCAATCCTTTGCTCCCATCTATGCGGACTTGTCCCTCAAGTACAACTGTTCAGGGCTAAATTTTGGG
AAGGTAGATGTTGGACGCTACACTGACGTTAGCACACGGTACAAAGTGAGCACATCACCCCTCACCAGACAG
CTCCCTACCCTGATTCTGTTCCAAGGCGGCAAGGAGGTCATTCGTCGGCCGCAGATTGACAAGAAAGGACGA
GCTGTCTCTTGGACCTTTTCTGAGGAGAATGTGATTCGAGAATTCAACTTGAATGAGCTATACCAACGAGCC
AAGAAGCACTCAAAGGGTGGAGACATGTCAGAAGAGAAGCCTGTGGACCCTGCTCCCACTACTGTGCCAGAT
GGGGAAAACAAGAAGGACAAATAG 
 
Figure S2: Examples of our Con_Mouse database entries. 
 
 
A summary statistics of our Con_Mouse database is presented in Table S4. It 
shows the number of sequences from each database or shared by different databases. 
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Table S4: Summary of our Con_Mouse database compared to other databases.a 
Total 
number of 
CDSs in 
Con_Mouse 
Shared in 
3 
databases 
Shared in 
NCBI and 
Ensembl 
Shared in 
NCBI and 
UCSC 
Shared in 
Ensembl 
and UCSC 
Unique 
in NCBI 
Unique in 
Ensembl 
Unique in 
UCSC 
67981 18587 1195 917 5363 6081 24495 11343 
aThe total number of genes is 26,017. In the simulation study, short reads are generated from 
only one transcript or CDS for one gene excluding alternative splicing forms. 
  
  
  
S4 Compilation of G
Genome 
 
In this section, we compiled the entire set of G
from the mouse genome using our consolidated database 
 
Figure S3: Seven
(adapted from E. N.
 
G-protein coupled receptors (GPCRs) are also known as seven
receptors (7TMRs) (Figure S3
protein (Guanine-nucleotide binding protein), which in turn activates downs
signaling pathways depending on the type of G
that are involved in many cellular signaling processes and they are common targets of 
therapeutic drugs. Members of GPCRs act as receptors for many signaling molecule
such as hormones, nucleotides, opiates, neurotransmitters and odorants, and GPCR 
families are also very divergent 
we took several steps to compile our list of GPCRs from our consolidated mouse CDS 
-Protein Coupled Receptors from the 
-protein coupled receptor proteins 
Con_Mouse.  
 
-transmembrane receptor model. 
 Moriyama, unpublished) 
-transmembrane 
). Upon binding of a ligand, the GPCR activates the G
-protein. GPCRs are important proteins 
(Kim, et al., 2000). Due to their low sequence similarity, 
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dataset, including BLAST (Altschul, et al., 1990), HMMER search with Pfam (Eddy, 
1998; Punta, et al., 2012), and 7TMRmine (Lu, et al., 2009). All files mentioned hereafter 
can be found at http://bioinfolab.unl.edu/emlab/gpcr_mouse/. 
 
BLAST approach: 
First, we used mouse GPCR protein sequences that were downloaded from 
GPCRDB (Vroling, et al., 2011) in the file “GPCR_mouse.fa” (3296 GPCR sequences) 
to perform similarity search using a BLAST program tblastn against our consolidated 
mouse coding sequence (CDS) set. If the search result was better than 99% identity and 
99% alignment coverage for both query and subject sequences, we marked this subject 
sequence as “G1” in the result file, “GPCR_table_RNA-seq.xlsx”. This was a very strict 
threshold and we considered these resultant sequences (2149 sequences obtained) highly 
likely to be GPCRs. 
Second, we went through each GPCR classification leaf group alignment from 
GPCRDB (“gpcr_families.txt” and alignments downloaded from 
http://www.gpcr.org/7tm/data/), and found “representative” sequences (209 sequences 
obtained). “Representative” sequence was defined as a GPCR sequence from rat 
(“rat_query.fa”), human (“human_query.fa”), or other vertebrate (“verte_query.fa”) that 
was present in the leaf classification group where mouse GPCR was missing in this 
group. Then, we used these “representative” sequences to perform tblastn search against 
our Con_Mouse database. We used 90% identity and 95% coverage for both query and 
subject sequences as the threshold if the “representative” sequence was from rat, 70% 
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identity and 95% coverage as the threshold if it was from human, and 70% identity and 
95% coverage as the threshold if it was from one of other vertebrates. The rationale here 
was that in one GPCR classification leaf group, if there were many GPCRs of other 
vertebrates but no mouse GPCRs, then it was possible that mouse GPCR was missing in 
GPCRDB in this leaf GPCR group. We marked sequences that passed the according 
thresholds as “G2” in the result file (30 sequences obtained). 
Third, we used subject sequences from step 2 that did not pass the threshold but 
still had promising scores (in the file “possible_GPCR_query.fa”) to perform blastx 
search against the NCBI non-redundant protein database. If they returned GPCR 
sequences from some species as first hits, we considered them as GPCRs. The rationale 
here was that these sequences were more closely related to some GPCRs rather than the 
“representative” sequences we chose earlier. Only 3 sequences were added in this step, 
“XM_003086424.1”, “XM_003085563.1” and “XM_003085916.1”, and they were 
marked as “G3”. 
Fourth, we used sequences found in previous steps (G1, G2, and G3) to perform 
blastn search against our Con_Mouse database again and added those sequences that 
showed better score than GPCRs determined in G1, G2 and G3; i.e., if a sequence that 
had not been found as GPCR before but was found in this step to be more similar to a 
query from G1, G2, or G3 than another sequence determined to be in the GPCR family 
X, then this sequence is considered to be a GPCR candidate from the family the query is 
thought to belong to. The rationale here is similar to PSI-BLAST that using results from 
previous search to increase the sensitivity to search for more similar sequences. 308 
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sequences were newly identified as GPCRs in this step. We marked these sequences as 
“G4”. 
 Fifth, we marked sequences as “G5” (18 sequences) if they were the best hits in 
the BLAST search result from “G1” step but failed to pass “G1” threshold and not found 
in previous steps. In general, sequences in G2 – G5 categories were considered likely to 
be GPCRs with more relaxed thresholds comparing to G1. 
All G1 to G5 sequences are marked in the result file, GPCR_table_RNA-seq.xlsx. 
 
HMMER with Pfam approach: 
In order to find the GPCR score threshold, we first used the profile hidden 
Markov models (HMMs) of the GPCR families identified in Pfam v26 database (the file 
“pfam_list_mouse_A.txt”, including 40 Pfam families) to search against all sequences in 
Swiss-Prot database (“2011_09” release) by profile HMM search using HMMER v3.0 
program. The first threshold was determined by the highest bit score of the non-GPCR 
sequences (sequences not in “GPCR_mouse.fa”) from Swiss-Prot in the search result (T1 
column of the file “pfam_thresholds.txt”; e.g., Pfam family “PF12003” had T1 score 
threshold of 181.9 and “PF03402” had T1 score threshold of 14.8). The second threshold 
was determined by the lowest bit score of the GPCR sequences (sequences in the file 
“GPCR_mouse.fa”) in the Swiss-Prot search result even though non-GPCR sequences 
might have higher bit scores (T2 column of “pfam_thresholds.txt”; e.g., “PF12003” had 
T2 bit score threshold of 13.1 and “PF03402” had T2 bit score threshold 13). We then 
used the profile HMMs of the GPCR families from Pfam to search against the translated 
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Con_Mouse database (“Ref_proteins.fa”, translation was done using the reading frame 
information from “Ref_seq_table_RNA-seq.xlsx”) and based on the thresholds (T1 and 
T2) we just determined. Sequences from our CDS with bit scores higher than the 
corresponding thresholds of the Pfam family were considered GPCRs. If a sequence in 
our mouse database passed the relatively more relaxed T2 and/or relatively stricter 
threshold T1, we marked the sequence with “G” in Pfam-T2 and/or Pfam-T1 column in 
the result file, respectively. A total of 1125 sequences passed the T1 thresholds and 2801 
sequences passed the T2 thresholds.  
 
7TMRmine approach: 
7TMRmine (Lu, et al., 2009) includes multiple GPCR sequence prediction 
methods. Among them, we are mostly interested in the result from SAM, GPCRHMM 
and SVM. Sequence alignment and modeling system (SAM) (Karplus, et al., 1998) uses 
profile hidden Markov models (HMMs) built from sequence alignments to predict protein 
family memberships. A profile HMM is a full probabilistic model based on a sequence 
alignment. GPCRHMM is developed by Wistrand et al. (2006). It uses profile HMMs, 
distinct loop length patterns, and amino acid composition differences among different 
regions in GPCRs for prediction. We used SAM, SAM1, and SAM2 from 7TMRmine 
(they use different E-value thresholds: 0.05, 4.23, and 6.52, respectively). Support vector 
machine (SVM) makes classification based on a hyperplane separating a remapped 
instance space. We used SVM-AA (using amino acid composition) and SVM-di (using 
dipeptide frequencies) from 7TMRmine. If a method in 7TMRmine system predicted a 
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sequence in our translated Con_Mouse (“Ref_proteins.fa”) to be a GPCR, we marked the 
sequence with “G” in the according method column in the result file.  
 
Results of mouse GPCR identification: 
To summarize, 2149 sequences passed BLAST strict threshold (G1 step, denoted 
as “blast_s” in Figure S4), and 2508 sequences passed BLAST relaxed threshold (G2-G5 
steps, “blast_r”). 1125 sequences passed T1 threshold of Pfam profile HMM search 
(“pfam_s”), and 2801 sequences passed T2 threshold (“pfam_r”). GPCRHMM predicted 
2566 sequences as GPCRs (“gpcrhmm”). 2246 sequences passed strict threshold we set 
for SAM (“sam”, E-value threshold 0.05) and 2580 sequences passed relaxed threshold 
(“sam2”, E-value threshold 6.52). SVM predicted 5870 sequences to be GPCRs 
(“svm_di”).  
In order to choose the most confident predictions, we looked at how prediction 
results overlap with each other (Figure S4). Numbers in the figure are the numbers of 
sequences predicted to be GPCRs using various methods. 
 
  
 
Figure S4: Number of GPCRs predicted by various methods and how the results 
overlap with each other 
The numbers outside the circles are the 
not GPCR. 
 
By comparing the resultant 
sequences, we decided to divide our prediction file (“GPCR_table_RNA
two parts. The first part is our most confident predictions (row 2
that consists predictions from GPCRHMM, SAM
pfam_r. The second part is the rest of the sequences that represent likely GPCR 
sequences but with less confidence (5107 sequences).
numbers of sequences from Con_Mouse predicted to be 
Venn diagrams and checking some of the actual 
-
–2759, 2758 sequences) 
, and the overlap between blast_r and 
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seq.xlsx”) into 
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S5 Compilation of Regulators of G Protein Signaling, Nuclear 
Receptors, and Their Domain Distance Matrices 
 
 The objectives of this project were 1) to compile all mouse Regulators of G-
protein signaling (RGS) and Nuclear Receptors (NR) and 2) to construct domain distance 
matrices to see how these proteins are related through domains. Both RGS and NR are 
medically important signal-transducing protein families, similarly important as GPCRs 
described in the previous section, and both have multiple domains. 
 
Introduction 
Regulators of G-protein signaling (RGS) are critical components of many cellular 
processes and pathways, e.g., intercellular signaling and asymmetric cell division (Wilkie 
and Kinch, 2005). Most RGS proteins and several of their relatives are involved in G-
protein GTPase-activating (GAP) activity. RGS proteins also interact with many other 
proteins and lipids that may cause positive or negative regulatory functions in addition to, 
or distinct from their GAP activities. The RGS are related by a conserved RGS domain of 
~130 amino acid residues. RGS domains have been found in many species from fungi, 
Dictyostelium discoideum, and animals (Ross and Wilkie, 2000). Family and domain 
relationship are showing in Figure S5. Many RGS proteins have other domains or motifs 
coexisted on their sequences. 
  
Figure S5: Mammalian RGS proteins. 
Left: Phylogenetic tree showing the relationship among five subfamilies RZ, R4, R7, R12 and RA. 
Right: Domain organization of different RGS sequences (from Ross and Wilkie, 2000). 
Abbreviations: APC, adenomotous polyposis coli; GGL, Gr
interaction domains; PP2A, protein phosphatase 2A. 
 
 
 
-like; DEP, PDZ, and 
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PTB, protein 
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Nuclear receptors (NR) are another extremely important proteins that are involved 
in almost all aspects of normal human physiology and also associated with many human 
diseases, and thus import therapeutic targets for pharmaceuticals (Olefsky, 2001). Many 
plant and synthetic chemicals, e.g., pesticides, industrial by-products and plastics 
components, have also been found to bind to nuclear receptors to trigger or disrupt their 
natural activities (Thornton, 2003). 
Nuclear receptors are multi-domain proteins only found in metazoans that bind to 
regions on DNA to regulate the transcription of specific genes. Most of nuclear receptors 
have the same domain arrangement with DNA-binding domain (DBD) and ligand 
binding domain (LBD) connected by a hinge region. The DNA-binding domain is 
responsible for targeting the receptor to highly specific DNA sequences and the ligand-
binding domain is to recognize specific hormonal and non-hormonal ligands. Usually in 
signal transduction pathways, nuclear receptors, upon ligand binding, form homo- or 
hetero-dimers and then to target specific DNA sequences to regulate the expression of the 
gene (Bertrand, et al., 2004). NR domain structure is presented in Figure S6. 
  
Figure S6: Structural organization of nuclear receptors.
(adapted from http://en.wikipedia.org/wiki/File:Nuclear_Receptor_Structure.png
 
RGS and NR protein compilation
RGS sequences were found 
with default parameters from the
al., 2012) v26.0 family PF00615 (RGS) and PF09128 (RGS
Con_Mouse database (“Ref_proteins”)
value calculated by HMMER to find all 
10 means that 10 expected false positive RGS sequences will be included in the resul
from the entire mouse protein set.
more RGS. 
 
 from the mouse genome 
by profile HMM search using program hmmsearch 
 HMMER v3.0 package (Eddy, 1998). Pfam 
-like) against 
. We used 10 as the threshold of the domain E
potential RGS sequence candidates. E
 We used this fairly large threshold to try to include 
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Nuclear receptor (NR) sequences were compiled in the exactly same fashion 
except that we used Pfam family PF00104 (Ligand-Binding Domain, LBD) and PF00105 
(DNA-Binding Domain, DBD) to search for NR sequences.  
In total, we obtained 154 RGS proteins (“RGS.fa”) and 156 NR proteins 
(“NR.fa”).  
 
Construction of domain distance matrices 
In order to prepare “domain evolution network” similar to the idea proposed by 
Holloway and Beiko (2010), we identified different domains co-existing in all RGS and 
NR protein sequences identified and constructed domain-to-protein distance matrices. 
This was part of a larger collaborative project. 
We used the compiled RGS sequence set to profile HMM search using HMMER 
program hmmsearch with default parameters against the Pfam database to find other 
domains on the sequences. We again used 10 as the threshold of the domain E-value 
calculated by HMMER to include more domains. This step was done to identify all other 
domains that coexist with RGS or RGS-like domain in our RGS sequences. We extracted 
the sequence of each domain from each RGS sequence. Each sequence of the domains 
found in an RGS protein was then used as the query for the similarity search using blastp 
against each sequence in the RGS sequence set. Each sequence in the RGS set was 
treated as a single database in the blastp search. The E-value was used as a distance 
measure between each domain sequence of an RGS sequence and each of RGS 
sequences. “0” or a very small E-value is expected if a domain sequence is highly similar 
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to a region of the sequence searched. A large E-value is expected, on the other hand, 
when a domain from sequence “A” is used for the search against sequence “B” where this 
domain does not exist. If a domain was not found on a sequence within the threshold E-
value of 10, we used 2870 as the maximum distance (based on the average lengths of 
query (100) and subject (700), we set the search space to be a constant number 70000, 
and the possible maximum E-value would be 2870 (based on λ=0.267 and Κ=0.041, 
using BLOSUM62)). We identified 48 domains from 154 RGS proteins, and the above 
process was repeated for every domain of every RGS sequence against all RGS 
sequences. An example of an RGS distance matrix is partially shown in Table S5. 
We identified 30 domains from 156 NR proteins, and the distance matrices were 
compiled in the same fashion. An example of an NR distance matrix is partially shown in 
Table S6. 
In total, we produced 154 (48 domains X 154 RGS protein sequences) and 156 
(30 domains X 156 NR protein sequences) distance matrices for RGS and NR proteins, 
respectively. All distance matrices can be found at: 
http://bioinfolab.unl.edu/emlab/gpcr_mouse/ 
These distance matrices serve as the input for reconstructing the domain evolution 
network. 
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Table S5: An example of an RGS domain-to-protein distance matrix.a 
Sequence 
 
Domain 
NM_207213.1|ENSM
UST00000041582|uc
009lpu.1 
NM_008488.1|uc009fq
v.1 
ENSMUST000000216
42 
ENSMUST000000974
60 
PF12761 3.00E-30 12 34 91 
PF06246 7.00E-22 1.9 41 2870 
PF08628 2.00E-62 5.6 39 52 
PF00787 1.00E-63 0.46 0.86 0.026 
PF02194 1.00E-92 0.81 0.099 1.6 
PF00615 3.00E-67 0.24 1.00E-06 1.00E-08 
PF09128 2870 2870 2870 2870 
PF00621 2870 2870 2870 2870 
PF00610 2870 2870 2870 2870 
PF06718 2870 2870 2870 2870 
PF00631 2870 2870 2870 2870 
PF00169 2870 2870 2870 2870 
PF00018 2870 2870 2870 2870 
PF00435 2870 2870 2870 2870 
PF04803 2870 2870 2870 2870 
PF02284 2870 2870 2870 2870 
PF08833 2870 2870 2870 2870 
PF00778 2870 2870 2870 2870 
PF02188 2870 2870 2870 2870 
PF02196 2870 2870 2870 2870 
PF11470 2870 2870 2870 2870 
PF00069 2870 2870 2870 2870 
PF07714 2870 2870 2870 2870 
PF11333 2870 2870 2870 2870 
aThis table shows the distance (BLAST E-value) between each domain sequence from the 
reference sequence (the first column) and any similar region found in each sequence. 
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Table S6: Example of an NR domain-to-protein distance matrix.a 
Sequence 
 
 
Domain 
ENSMUST00000110
418 
ENSMUST0000004485
8|uc008cay.1 
NM_010936.2|ENSMU
ST00000023504|uc00
7zeq.1 
NM_011934.2|ENSMU
ST00000021680|ENSM
UST00000110207|ENS
MUST00000167891|uc
007oht.1|uc007ohw.1 
PF12497 2870 2870 2870 2870 
PF00104 5.00E-04 5.00E-108 5.00E-13 4.00E-22 
PF02159 2870 2870 2870 2870 
PF03489 2870 2870 2870 2870 
PF00105 2.00E-21 1.00E-42 1.00E-19 3.00E-23 
PF11825 5.2 6.00E-20 6.8 4.9 
PF07352 2870 2870 2870 2870 
PF02166 2870 2870 2870 2870 
PF07371 2870 2870 2870 2870 
PF02161 2870 2870 2870 2870 
PF12837 2870 2870 2870 2870 
PF06600 2870 2870 2870 2870 
PF12577 2870 2870 2870 2870 
PF12782 2870 2870 2870 2870 
PF02535 2870 2870 2870 2870 
PF08143 2870 2870 2870 2870 
PF03408 2870 2870 2870 2870 
PF12390 2870 2870 2870 2870 
PF07967 2870 2870 2870 2870 
PF06827 2870 2870 2870 2870 
PF03854 2870 2870 2870 2870 
PF10080 2870 2870 2870 2870 
PF06215 2870 2870 2870 2870 
PF03468 2870 2870 2870 2870 
aThis table shows the distance (BLAST E-value) between each domain sequence from the 
reference sequence (the second column) and any similar region found in each sequence. 
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